The 20 Best Renal Cell Carcinoma (RCC) Doctors Near Me in Bellaire, TX

Kamran Ahrar is an Interventional Radiologist practicing medicine in Houston, Texas. Dr. Ahrar is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Ureterocele, Liver Embolization, and Nephrectomy.

Dr. Aihua Edward Yen is an oncologist specializing in genitourinary medical oncology. He is an Assistant Professor of Medicine - Hematology and Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine (BCM). He is also an Instructor of Medicine - Hematology and Oncology Section at BCM and a Urology Oncology specialist at the Bladder Cancer Center at BCM’s Dan L Duncan Comprehensive Cancer Center.Dr. Yen’s clinical interests include: prostate cancer and genitourinary cancers.Dr. Yen received his medical degree from Baylor College of Medicine, where he also completed his residency in internal medicine and a fellowship in hematology and medical oncology.Dr. Yen is board-certified in Medical Oncology by the American Board of Internal Medicine. In addition to English, Dr. Yen speaks Mandarin. Dr. Yen is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Non-Muscle Invasive Bladder Cancer. Dr. Yen is currently accepting new patients.

Richard E. Link, M.D., Ph.D., Associate Professor, is a Board-certified and fellowship-trained urologist specializing in the treatment of urologic disease affecting the kidney, ureter, and prostate. He focuses on the use of laparoscopic, robotic-assisted, percutaneous, and endoscopic techniques to treat kidney tumors, renal and ureteral obstruction, and urinary tract stones. He directs the BCM Division of Endourology and Minimally Invasive Surgery and is active, nationally, in teaching these techniques to other urologists through the American Urological Association Office of Education. He has also directed the BCM fellowship program in Minimally Invasive Urologic Surgery since 2008. Dr. Link has been an early pioneer in the development of laparoendoscopic single-site donor nephrectomy, a less invasive laparoscopic technique in which a donor kidney can be removed via only a single, small peri-umbilical incision for transplantation. He serves as Director of Living Donor Procurement for several major kidney transplant programs in Houston, including CHI/SLEH/BCM, Texas Children's Hospital, and the Houston Methodist Hospital. He also co-directs the BCM Comprehensive Stone Clinic, which provides a state-of-the-art multidisciplinary tertiary referral center for patients with complex kidney stones. Dr. Link completed his Ph.D. in Molecular and Cellular Physiology at Stanford University. His research laboratory studies the genetic basis for renal cell carcinoma and urinary tract stone disease using a combination of genetically engineered mouse models, stem cell biology, and sophisticated whole genome molecular techniques. His clinical research interests include surgical simulation, decision analysis modeling, and the application of 3D reconstruction and printing techniques to surgical education. Dr. Link is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Link is currently accepting new patients.

Martha Mims, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Martha Mims specializes in Medical Oncology and works at BCM Medicine - Hem/Onc. To make an appointment, please call (713) 798-3750. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Mims is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Hypereosinophilic Syndrome, Essential Thrombocythemia, Non-Hodgkin Lymphoma, and Clear Cell Sarcoma. Dr. Mims is currently accepting new patients.

Seth P. Lerner, MD, is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology, in the Scott Department of Urology, Baylor College of Medicine. He is Director of Urologic Oncology and the Multidisciplinary Bladder Cancer Program and Faculty Group Practice Medical Director for the Urology Clinic. He earned his medical degree from Baylor College of Medicine, completed a surgical internship at Virginia Mason Hospital in Seattle, and returned to Baylor for his residency training. He completed a two-year fellowship at the University of Southern California in urologic oncology and reconstructive surgery under Peter Jones and Don Skinner before returning to join the full-time Baylor faculty in 1992. His clinical practice, education, and research activities are devoted to urologic oncology and particularly lower and upper tract urothelial cancer. Dr. Lerner is author of more than 160 peer-reviewed articles, and co-editor of a comprehensive Textbook of Bladder Cancer. Dr. Lerner is an active member of the prestigious American Association of Genitourinary surgeons and is listed routinely among America's Top Doctors and Best Doctors in America. He established and directs the multi-disciplinary Bladder Cancer Research Program at Baylor, and his research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, targeted molecular therapeutics, and outcomes of radical cystectomy and pelvic lymphadenectomy. He has 22 years of experience as a clinical investigator for both NCI and industry funded clinical trials. He is the PI of the ongoing SWOG NCI Phase III trial comparing extended vs. standard pelvic lymphadenectomy at time of radical cystectomy for muscle invasive bladder cancer. He is active in the leadership of several national bladder cancer research enterprises including chair of the Local Bladder Cancer committee of SWOG, co-chair of the NCI's Bladder Cancer Task Force and the Analysis Working Group of The Cancer Genome Atlas Project for muscle invasive bladder cancer. He is very active in the Bladder Cancer Advocacy Network (BCAN) as a member of the Board of Directors, past chair of the Bladder Cancer Think Tank and co-chair of the management committee of the Bladder Cancer Research Network. Dr. Lerner is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy. Dr. Lerner is currently accepting new patients.

Carly Gardner is a Radiologist practicing medicine in Houston, Texas. She has been practicing medicine for over 17 years. Dr. Gardner is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Gallbladder Disease, Lemierre Syndrome, Visceromegaly, and Tenosynovitis. Dr. Gardner is board certified in American Board Of Radiology, 2015.

Mohamed Abdelsalam is an Interventional Radiologist practicing medicine in Houston, Texas. Dr. Abdelsalam is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Liver Cancer, Liver Embolization, and Thrombectomy.

Dharam Kaushik is a Urologist practicing medicine in Houston, Texas. Dr. Kaushik is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Kaushik is currently accepting new patients.

Jed-sian Cheng is a Urologist practicing medicine in Houston, Texas. Dr. Cheng is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Enlarged Prostate (BPH), Urothelial Cancer, Ureteroscopy, and Nephrectomy.

Jonathan Reed is a Radiologist practicing medicine in Houston, Texas. Dr. Reed is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His clinical expertise encompasses Pleural Effusion, Pleurisy, Gas Bloat Syndrome, Vertebroplasty, and Bone Graft.

Raj Satkunasivam is a Urologist practicing medicine in Houston, Texas. Dr. Satkunasivam is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Cystectomy.

Arpit Rao is a Hematologist practicing medicine in Houston, Texas. Dr. Rao is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Adult Soft Tissue Sarcoma.

Dr. Sravanti Teegavarapu specializes in benign and malignant hematological diseases. She is an Assistant Professor of Medicine - Hematology and Oncology and Medical Director of Hematology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.Dr. Teegavarapu’s clinical interests include lymphomas and other blood diseases. Dr. Teegavarapu received her medical degree from the Armed Forces Medical College in Pune, India.She completed her residency at University of North Dakota in Fargo and postdoctoral fellowship at the M.D. Anderson Cancer Center in Houston. She also completed a fellowship at Houston Methodist Hospital/Weill Cornell Medical College.Dr. Teegavarapu is board-certified by the American Board of Internal Medicine, American Board of Hematology and the American Board of Oncology. In addition to English, Dr. Teegavarapu speaks Telugu and Hindi. Dr. Teegavarapu is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Diffuse Large B-Cell Lymphoma (DLBCL), and Large-Cell Immunoblastic Lymphoma. Dr. Teegavarapu is currently accepting new patients.

Dr. Benjamin Musher is a medical oncologist specializing in gastrointestinal cancers. He is the Medical Director of Medical Oncology and Director of the Gastrointestinal Cancer Program at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine (BCM), where he also holds the Barry Smith Endowed Professorship.Dr. Musher received an AB in Social Studies from Harvard University and his MD with Honors from BCM. He completed his residency in internal medicine at the University of Washington’s Department of Medicine, where he was an attending physician. He was later an attending physician and fellow in the Division of Hematology-Oncology at the University of Pennsylvania.Dr. Musher received the Oncology Faculty Educator of the Year for six consecutive years and the Fulbright & Jaworski L.L.P. Faculty Excellence Award, which recognizes BCM faculty for excellence in teaching and evaluation. He has also been recognized with several awards for going above and beyond to deliver exceptional patient experiences; and was named a Top Doctor in 2015 by Houstonia Magazine.Dr. Musher is board-certified in Medical Oncology from the American Board of Internal Medicine and is a member of the American Society of Clinical Oncology. Dr. Musher is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, and Familial Colorectal Cancer. Dr. Musher is currently accepting new patients.

Jennifer Wang is a primary care provider, practicing in Hematologist in Houston, Texas. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Upper Tract Urothelial Carcinoma (UTUC).

Peter Black is a Urologist practicing medicine in Houston, Texas. Dr. Black is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

Tung Shu is a Urologist practicing medicine in Houston, Texas. Dr. Shu is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Nephrectomy, and Reconstructive Urology Surgery.

Sung Kim is a Urologist practicing medicine in Houston, Texas. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Prostatectomy.

Guilherme Godoy, M.D., assistant professor, specializes in urologic oncology. Dr. Godoy earned his medical degree from Fundacao Universitaria do ABC in Sao Paulo, Brazil. His training includes an internship and residency in urology at Santa Casa De Sao Paulo in Vila Buarque, Brazil, and a fellowship in urologic oncology at Baylor College of Medicine. Dr. Godoy specializes in urologic oncology and management of patients with bladder cancer, kidney cancer, prostate cancer, and testis cancer. Dr. Godoy is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Ureterocele, Urothelial Cancer, Reconstructive Urology Surgery, and Nephrectomy. Dr. Godoy is currently accepting new patients.

Dr. Wesley Mayer specializes in advanced minimally invasive surgical treatments for urologic diseases including robotic, laparoscopic (including single-site), endourologic, laser, and percutaneous surgery. He has a special interest in kidney cancer, kidney stones, upper urinary tract reconstruction, adrenal masses, and transplant urology. His other areas of expertise include the evaluation and treatment of adrenal gland masses, elevated PSA, prostatic enlargement, and blood in the urine. Dr. Mayer graduated from Baylor College of Medicine, and completed his internship in general surgery and his urology residency at the University of Pennsylvania. He was fellowship-trained in minimally invasive urology at Baylor College of Medicine's Scott Department of Urology. Dr. Mayer has published research on robotic partial nephrectomy, advanced single-site donor nephrectomy, and treatment of kidney stones. In addition to having been an instructor for the American Urological Association's Mentored Laparoscopy Course, he has served as the Urology Chairman of the Methodist Practice Improvement Committee and is currently the Associate Program Director of the Baylor Urology Residency Program. Dr. Mayer has been selected as a Top Urologist in Houston, TX in The Leading Physicians of the World. Dr. Mayer is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Folliculitis, Boils, Nephrectomy, and Ureteroscopy. Dr. Mayer is currently accepting new patients.